LyGenesis Inc, co-founded by PLRC’s Dr. Eric Lagasse, Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also Closes $11 Million Convertible Debt Financing.